The purpose of the ampoule 2.2ml №5

Composition

Target t ointment
100 g ointment Objective T contain: Cartilago suis D2, Funiculus umbilicalis suis D2, Embryo suis D2, Placenta suis D2 for 0.001 g, Toxicodendron quercifolium D2 0.27 g, Arnica montana D2 0.3 g, Solanum dulcamara D2 0.075 g, Symphytum officinale D8 0.75 g, Sanguinaria canadensis D2 0.225 g, Sulfur D6 0.27 g, Nadidum D6 0.01 g, Coenzymum A D6 0.01 g, Acidum alpha-liponicum D6 0.01 g, Natrium oxalaceticum D6 0, 01 g, Acidum silicicum D6 1.0 g;
50 g in a tube.

Target t sublingual tablets
1 pill (300 mg) contains: Cartilago suis D4, Funiculus umbilicalis suis D4, Embryo suis D4, Placenta suis D4 0.3 mg each, Toxicodendron quercifolium D2 0.54 mg, Arnica montana D1 0.6 mg, Solanum dulcamara D2 0, 15 mg, Symphytum officinale D8 0.15 mg, Sanguinaria canadensis D3 0.45 mg, Sulfur D6 0.54 mg, Acidum silicicum D6 3.0 mg, Nadidum D6, Coenzymum A D6, Acidum alpha-liponicum D6, Natrium oxalaceticum D6 0.03 mg;
50 pcs. packaged.

Target t injection
1 ampoule (2 ml) of solution contains: Cartilago suis D6, Funiculus umbilicalis suis D6, Embryo suis D6, Placenta suis D6 2 mg, Rhus toxicodendron D2 10 mg, Arnica D4 200 mg, Solanum dulcamara D3, Symphytum officale D6 10 mg, Sanguinaria canadensis D4 3 mg, Sulfur D6 3.6 mg, Nadidum D8, Coenzymum A D8, Acidum alpha-liponicum D8, Natrium oxalaceticum D8 2 mg;
2 ml in ampoules of 5 or 100 pcs.

Mechanism of action

The purpose of T is a complex homeopathic drug with chondroprotective, chondrostimulating, regenerating, metabolic and analgesic effects. Therapeutic efficacy The purpose of T is determined by the properties of plant, biological, mineral components, as well as stimulants of metabolic processes included in its composition. T-target has analgesic (Rhus toxicodendron), anti-inflammatory (Dulcamara) action; normalizes impaired metabolism in cartilage, synovial membrane and synovial fluid (Nadid, Coenzym A, A-Liponsaure, Natrium oxalaceticum), helps restore damaged bones and periosteum (Symphytum), strengthens ligaments and connective tissue (Acidum silicicum colloidale).

Indications and usage

Objective T is used in the treatment of the following conditions:

• degenerative diseases of the joints (arthrosis - gonarthrosis, polyarthrosis, spondyloarthrosis, shoulder scapular periarthritis), spinal column (osteochondrosis) and ligamentous structures (chondropathy, tendinopathy);
• metabolic osteopathy; №consequences of spinal injuries and fractures;
• pathogenetic therapy of the “lumbar and cervical spine syndrome” (lumbo-sacral disorders, cervical migraine);
• rheumatic diseases of the musculoskeletal system (rheumatoid polyarthritis, Reiter's syndrome).

Dosage and administration

Injection: usually twice a week, 1 ampoule subcutaneously, intramuscularly, intracutaneously, intravenously, intra-articularly or periarticularly or, if necessary, paravertebral (by the “blister” method). For diseases of large joints, inject 2 ampoules in each case. Objective T in one injection. In acute cases, daily injections are possible. Objective T.

Pills keep in mouth until complete resorption, 1 pill 3-5 times a day.

Ointment: impose on the affected place; Massaging, gently rub 2-5 times a day. If necessary, you can apply a gauze bandage.

Contraindications

Hypersensitivity to the poison of sumac, hard-to-color and other components of the drug.

Adverse reactions

In some cases, at the beginning of therapy, the purpose of T injections can be pain in the joints, which can be removed by anti-inflammatory therapy or local anesthetics; skin allergic reactions.

Special notes

To enhance therapeutic efficacy, the simultaneous use of all three dosage forms of the drug is recommended. Objective T.
For joint diseases, combination therapy with Traumeel C is recommended.

Storage conditions

In a dry, dark place at room temperature.